Literature DB >> 9972767

Pre- versus postinjury effects of intravenous GABAergic anesthetics on formalin-induced Fos immunoreactivity in the rat spinal cord.

I Gilron1, R Quirion, T J Coderre.   

Abstract

UNLABELLED: We evaluated the suppression of spinal Fos-like immunoreactivity (FLI) by i.v. anesthetics in the rat formalin model. Preformalin injection (1.5% subcutaneously) treatment groups included i.v. saline controls and three i.v. GABAergic anesthetic groups (pentobarbital 20 mg/kg, propofol 10 mg/kg, or alphaxalone 1.5 mg/kg; n = 12 per group). After perfusion 2 h postformalin, spinal cords were dissected, sliced at 30 microm, and processed by immunoperoxidase staining with an antibody against the Fos protein. Quantification and determination of the laminar distribution of Fos-labeled nuclei were performed at the L4-5 spinal level ipsilateral to formalin injection. Drug groups demonstrating FLI suppression were comparatively studied in a 5-min postformalin treatment group. Pentobarbital pretreatment failed to suppress FLI. However, significant reductions (percent decrease) of FLI were observed with propofol (63%) and alphaxalone (30%) compared with saline controls. Pre- versus postformalin comparison studies showed that propofol, but not alphaxalone, suppressed FLI more effectively when given preformalin. Given the observed inconsistencies between this study of Fos expression and our previous behavioral study, it is questionable whether anesthetic modulation of noxious stimulus-induced FLI parallels that of behavioral responses. IMPLICATIONS: In this study, we examined whether i.v. general anesthetics (propofol, alphaxalone, and pentobarbital) prevent injury-induced spinal cord changes. We measured spinal Fos protein after rats received anesthetics before versus after a formalin injection. Fos inhibition patterns were inconsistent with behavioral studies of these anesthetics, suggesting that Fos inhibition does not always correlate with behavioral analgesia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9972767     DOI: 10.1097/00000539-199902000-00036

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Effects of general anesthetics on substance P release and c-Fos expression in the spinal dorsal horn.

Authors:  Toshifumi Takasusuki; Shigeki Yamaguchi; Shinsuke Hamaguchi; Tony L Yaksh
Journal:  Anesthesiology       Date:  2013-08       Impact factor: 7.892

2.  The antinociceptive and antihyperalgesic effects of topical propofol on dorsal horn neurons in the rat.

Authors:  Kenichi Takechi; Mirela Iodi Carstens; Amanda H Klein; E Carstens
Journal:  Anesth Analg       Date:  2013-01-21       Impact factor: 5.108

3.  Profound swim stress-induced analgesia with ketamine.

Authors:  Asma Hayati Ahmad; Zalina Ismail; Myo Than; Azhar Ahmad
Journal:  Malays J Med Sci       Date:  2008-01

4.  Short-term anesthesia inhibits formalin-induced extracellular signal-regulated kinase (ERK) activation in the rostral anterior cingulate cortex but not in the spinal cord.

Authors:  Keri K Tochiki; Maria Maiarù; James R C Miller; Stephen P Hunt; Sandrine M Géranton
Journal:  Mol Pain       Date:  2015-08-14       Impact factor: 3.395

5.  Effects of intraoperative propofol-based total intravenous anesthesia on postoperative pain in spine surgery: Comparison with desflurane anesthesia - a randomised trial.

Authors:  Wei-Lin Lin; Meei-Shyuan Lee; Chih-Shung Wong; Shun-Ming Chan; Hou-Chuan Lai; Zhi-Fu Wu; Chueng-He Lu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 6.  Identifying c-fos Expression as a Strategy to Investigate the Actions of General Anesthetics on the Central Nervous System.

Authors:  Donghang Zhang; Jin Liu; Tao Zhu; Cheng Zhou
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

7.  Propofol produces preventive analgesia via GluN2B-containing NMDA Receptor/ERK1/2 Signaling Pathway in a rat model of inflammatory pain.

Authors:  Qiu Qiu; Liting Sun; Xiao-Min Wang; Amy C Y Lo; Kar Lok Wong; Pan Gu; Sau Ching Stanley Wong; Chi Wai Cheung
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.